Sie suchten nach: punteġġi (Maltesisch - Englisch)

valuri limiti tal-punteġġi-z
z-scores threshold values

l-għadd ta’ punteġġi tpv għas- suxxetibilità
number of tpv score mutations**

punteġġi adcs-cgic ta’ <4 jindikaw titjib.
adcs-cgic scores <4 indicate improvement.

bejn l-2005 u l-2007 il-punteġġi stabbilizzaw.
between 2005 and 2007 scores have stabilised.

titjib fil-punteġġi facit inżamm sal-Ġimgħa 52.
improvements in facit scores were maintained through week 52.

medja tal- bidliet mill- linja bażi fil- punteġġi bpi.
mean changes from baseline in bpi scores.

enf * ġdid l- għadd ta ’ punteġġi tpv għas - suxxetibilità **
number of tpv score mutations**

figura 1: tibdil medju mil-linja bażi fil-punteġġi bpi.
figure 1: mean changes from baseline in bpi scores.

għall-updrs, punteġġi ogħla jindikaw severità akbar ta’ indeboliment
for the updrs, higher scores indicate greater severity of impairment

il- punteġġi kienu madwar 23 punt fil- bidu ta 'l- istudju.
in the first study of restless legs syndrome, symptom scores fell by between 12.8 and 14.0 points after 12 weeks in patients taking mirapexin, compared with a decrease of 9.3 points in the patients taking placebo.

punteġġi ta’ sensittività ġenotipika ma nkisbux għal pazjenti kollha fil-linja bażi.
genotypic sensitivity scores were not obtained for all patients at baseline.

figura 1: medja tal-bidliet mil-linja bażi fil-punteġġi bpi.
figure 1: mean changes from baseline in bpi scores.

il-punteġġi tal-intensità u tal-effiċjenza tar-riċerka u l-iżvilupp17
r&d intensity and efficiency scores17

il-punteġġi pep segwew mudell simili ta’ titjib għal dawk tal-punteġġi ielt u ipe.
the pep scores followed a similar pattern of improvement to the ielt and ipe scores.

il-maġġoranza tal-pazjenti kellhom punteġġi apache ii ta’ ≤ 20 u ftit biss kienu newtropeniċi.
the majority of patients had apache ii scores ≤ 20 and very few were neutropenic.

95% intervall ta ’ konfidenza ghad- differenza bejn il- punteġġi ta ’ methotrexate u humira. b
methotrexate b 95% confidence intervals for the differences in change scores between methotrexate and humira. c based on rank analysis d joint space narrowing

amethotrexate b95% intervall ta’ konfidenza ghad-differenza bejn il-punteġġi ta’ methotrexate u humira.
amethotrexate b95% confidence intervals for the differences in change scores between methotrexate and humira. cbased on rank analysis djoint space narrowing

ara li jkollok xi tip ta’ sistema għall-għoti tal-punteġġi: numri minn 0-10 jew gradi.
have some kind of scoring system: numbers 0-10 or grading.

minn dawn il-pazjenti, 64.5% kellhom punteġġi selena sledai ta’ ≥ 10 fil-linja bażi.
of these patients, 64.5% had selena sledai scores ≥ 10 at baseline.

ir-rati ta’ rispons skond il-5 punteġġi tal-ġilda kienu 36% u 27%, rispettivament.
the response rates according to the 5 skin scores were 36% and 27%, respectively.